Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Sahuquillo‐Torralba, Antonio
51  Ergebnisse:
Personensuche X
?
1

Dose reduction is a feasible strategy in patients with plaq..:

Daudén, Esteban ; Escario, Elena ; Martos‐Cabrera, Luisa...
International Journal of Dermatology.  63 (2024)  4 - p. 503-511 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Certolizumab pegol effectiveness, survival and safety in pa..:

Sahuquillo‐Torralba, Antonio ; Mansilla‐Polo, Miguel ; Pujol‐Marco, Conrad...
International Journal of Dermatology.  , 2024
Link: https://doi.org/10.1111/..
 
?
3

Clinicopathological characteristics of cutaneous and mucocu..:

Palacios‐Diaz, Rodolfo David ; Sahuquillo‐Torralba, Antonio ; Rocamora‐Durán, Vicenç...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft.  21 (2023)  5 - p. 473-480 , 2023
Link: https://doi.org/10.1111/..
 
?
4

Klinisch‐pathologische Eigenschaften kutaner und mukokutane..:

Palacios‐Diaz, Rodolfo David ; Sahuquillo‐Torralba, Antonio ; Rocamora‐Durán, Vicenç...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft.  21 (2023)  5 - p. 473-481 , 2023
Link: https://doi.org/10.1111/..
 
?
5

High adherence to secukinumab in patients with moderate to ..:

Martos‐Cabrera, Luisa ; Llamas‐Velasco, Mar ; Armesto, Susana...
International Journal of Dermatology.  62 (2022)  3 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
6

Effectiveness and safety of guselkumab for the treatment of..:

del Alcázar, Elena ; López‐Ferrer, Anna ; Martínez‐Doménech, Álvaro...
Dermatologic Therapy.  35 (2022)  2 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
7

Fast and sustained improvement of patient‐reported outcomes..:

Chicharro, Pablo ; Llamas‐Velasco, Mar ; Armesto, Susana...
Dermatologic Therapy.  35 (2022)  8 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
8

Secukinumab is effective and safe in the long‐term treatmen..:

Chicharro, Pablo ; Llamas‐Velasco, Mar ; Armesto, Susana...
Dermatologic Therapy.  35 (2022)  12 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
9

Accuracy of SCORTEN and ABCD‐10 to predict mortality and th..:

Torres‐Navarro, Ignacio ; Briz‐Redón, Álvaro ; Botella‐Casas, Gonzalo...
The Journal of Dermatology.  47 (2020)  10 - p. 1182-1186 , 2020
Link: https://doi.org/10.1111/..
 
?
10

One Dose Risankizumab Effectiveness in Psoriasis: A Real‐Li..:

Magdaleno-Tapial, Jorge ; Ortiz-Salvador, José María ; Santos-Alarcón, Sergio...
Dermatologic Therapy.  2024 (2024)  1 - p. , 2024
Link: https://doi.org/10.1155/..
 
?
11

Efficacy of Risankizumab in Patients with Suboptimal Respon..:

Magdaleno-Tapial, Jorge ; Ortiz-Salvador, José María ; Sánchez-Carazo, José Luis...
Dermatologic Therapy.  2024 (2024)  1 - p. , 2024
Link: https://doi.org/10.1155/..
 
?
12

Drug survival and safety of biosimilars and originator adal..:

Phan, Duc Binh ; Jourdain, Hugo ; González-Quesada, Alicia...
BMJ Open.  13 (2023)  7 - p. e075197 , 2023
Link: https://doi.org/10.1136/..
 
?
13

Safety of biologic therapy in combination with methotrexate..:

Lluch-Galcerá, Juan José ; Carrascosa, Jose Manuel ; González-Quesada, Alicia...
British Journal of Dermatology.  190 (2023)  3 - p. 355-363 , 2023
Link: https://doi.org/10.1093/..
 
?
14

32428 Secukinumab is effective and safe in the treatment of..:

Reolid, Alejandra ; Armesto, Susana ; Sahuquillo-Torralba, Antonio
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. AB108 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Differences in epidemiology, comorbidities and treatment ch..:

Ruiz Genao, Diana P. ; Carretero, Gregorio ; Rivera-Diaz, Raquel...
British Journal of Dermatology.  187 (2022)  5 - p. 817-820 , 2022
Link: https://doi.org/10.1111/..
 
1-15